Table 2.

Postoperative outcomes of all patients undergoing esophageal cancer surgery, as compared between the COVID-19 pandemic cohort and the control cohort

	COVID-19 pandemic group [N = 139]	Control cohort [N = 168]	p value
Complications
Yes	89 (64.0)	107 (63.7)	0.951
CCI score [mean (SD)]	41.2 (25.5)	39.8 (20.2)	0.699
Maximum Clavien–Dindo			0.317
I	5 (3.6)	8 (4.8)
II	33 (23.7)	35 (20.8)
III	25 (18.0)	39 (23.2)
IV	25 (18.0)	24 (14.3)
V	5 (3.6)	2 (1.2)
Pulmonary complications	45 (32.4)	50 (29.9)	0.647
Pneumonia	20 (14.4)	32 (19.0)	0.297
Respiratory failure requiring reintubation	19 (13.7)	14 (8.3)	0.127
ICU admission	69 (49.6)	98 (58.3)	0.128
ICU admission, days [median (IQR)]	0 (0–4)	1 (0–3)	0.686
Length of hospital stay, days [median (IQR)]	12 (9–16.25)	12.5 (9–17.75)	0.430
Readmission within 30 days
Yes	16 (11.5)	14 (8.3)	0.184
30-day mortality
Yes	5 (3.6)	3 (1.8)	0.263

Data are expressed as n (%) unless otherwise specified

CCI Comprehensive Complications Index, COVID-19 coronavirus disease 2019, ICU intensive care unit, IQR interquartile range, SD standard deviation